2 results match your criteria: "Critical Care Coordinating Center (4Cs)[Affiliation]"
Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill.
Int J Mol Sci
April 2023
Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti-inflammatory treatment with low dose dexamethasone has been shown to reduce mortality in COVID-19 patients requiring oxygen therapy. However, the mechanisms of action of corticosteroids have not been extensively studied in critically ill patients in the context of COVID-19.
View Article and Find Full Text PDFPreoperative frailty screening, assessment and management.
Curr Opin Anaesthesiol
February 2023
Critical Care Coordinating Center (4Cs), Brussels.
Purpose Of Review: To highlight the importance of frailty assessment in thoracic surgery patients.
Recent Findings: Frailty results from an accelerated loss of functional reserve associated with ageing and leads to increased vulnerability following surgery. It is a complex and multidimensional syndrome involving physiological and psychosocial systems.